53. シェーグレン症候群 Sjogren syndrome Clinical trials / Disease details


臨床試験数 : 283 薬物数 : 320 - (DrugBank : 101) / 標的遺伝子数 : 56 - 標的パスウェイ数 : 181

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04909255
(ClinicalTrials.gov)
March 23, 202121/4/2021Beta-3 Agonist and Anti-muscarinic Agent for Sjogren's Syndrome With Overactive BladderThe Therapeutic Effect of Beta-3 Agonist and Anti-muscarinic Agent on Overactive Bladder Among Sjogren's Syndrome PatientSjogren's Syndrome;Overactive Bladder SyndromeDrug: mirabegron;Drug: oxybutynin, tolterodine, solifenacinChina Medical University HospitalNULLRecruiting20 YearsN/AAll50Phase 4Taiwan